Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic Valve

Abstract

valve implantation (TAVI) has enabled treating high-risk patients with aortic stenosis who are ineligible for SAVR, and has become a standard procedure for aortic stenosis in W ith an aging population, the number of patients undergoing aortic valve replacement with bioprosthetic valves (BPV) is increasing, 1,2 as is the number of patients with atrial fibrillation (AF). 3,4 Although surgical aortic valve replacement (SAVR) is an established procedure for aortic valve disease, transcatheter aortic Editorial p ????